- Antituberculosis antibiotic used as second-line therapy
- Inhibits the ATP synthase proton pump in mycobacteria
- Member of the diarylquinoline class of antibiotics
- Adverse events include QTc prolongation, hepatitis, and possibly an increased risk of death
- Others: arthralgias, dizziness, headache, hyperuremia, insomnia, myalgia, nausea, prolonged QTc, pruritus, and vomiting
